Variant report

Variant	esv3441228
Chromosome Location	chr4:3367804-3370302
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:19)
CpG islands
(count:61)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:19 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTCF	chr4:3368887-3369076	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr4:3368740-3368890	BE2_C	brain:	n/a	n/a
3	CTCF	chr4:3370293-3370376	GM19239	blood:	n/a	n/a
4	CTCF	chr4:3368900-3369050	HRE	kidney:	n/a	n/a
5	CTCF	chr4:3368840-3368990	AG04450	lung:	n/a	n/a
6	CTCF	chr4:3368960-3369110	HRE	kidney:	n/a	n/a
7	CTCF	chr4:3368960-3369110	HBMEC	blood vessel:	n/a	n/a
8	CTCF	chr4:3368880-3369030	HBMEC	blood vessel:	n/a	n/a
9	CTCF	chr4:3368860-3369010	HepG2	liver:	n/a	n/a
10	CTCF	chr4:3368760-3368910	RPTEC	kidney:	n/a	n/a
11	HMGN3	chr4:3367750-3367842	K562	blood:	n/a	n/a
12	MAX	chr4:3368428-3369147	HepG2	liver:	n/a	chr4:3368655-3368665 chr4:3368654-3368664
13	MYC	chr4:3370140-3370147	MCF-7	breast:	n/a	n/a
14	MYC	chr4:3368980-3369124	H1-hESC	embryonic stem cell:	n/a	n/a
15	POLR2A	chr4:3370032-3370520	HepG2	liver:	n/a	n/a
16	POLR2A	chr4:3370243-3370258	MCF-7	breast:	n/a	n/a
17	POLR2A	chr4:3368369-3368382	K562	blood:	n/a	n/a
18	RAD21	chr4:3368799-3369208	H1-hESC	embryonic stem cell:	n/a	n/a
19	USF1	chr4:3368531-3368766	HepG2	liver:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:3369023-3369073	HUVEC	blood vessel:	n/a
2	chr4:3369023-3369073	CMK	blood:	n/a
3	chr4:3369023-3369073	NH-A	brain:	n/a
4	chr4:3369023-3369073	MCF-7	breast:	n/a
5	chr4:3369023-3369073	PFSK-1	brain:	n/a
6	chr4:3369023-3369073	NHDF-neo	bronchial:	n/a
7	chr4:3369023-3369073	MCF10A-Er-Src	breast:	n/a
8	chr4:3369023-3369073	SAEC	small airway:	n/a
9	chr4:3369023-3369073	AG10803	skin:	n/a
10	chr4:3369023-3369073	NHBE	bronchial:	n/a
11	chr4:3369023-3369073	HRPEpiC	eye:	n/a
12	chr4:3369023-3369073	H1-hESC	embryonic stem cell:	embryo
13	chr4:3369023-3369073	ProgFib	skin:	n/a
14	chr4:3369023-3369073	NT2-D1	testis:	n/a
15	chr4:3369023-3369073	K562	blood:	n/a
16	chr4:3369023-3369073	GM12892	blood:	n/a
17	chr4:3369023-3369073	BJ	skin:	n/a
18	chr4:3369023-3369073	NB4	blood:	n/a
19	chr4:3369023-3369073	HAEpiC	amniotic membrane:	n/a
20	chr4:3369023-3369073	GM12891	blood:	n/a
21	chr4:3369023-3369073	ovcar-3	ovarian:	n/a
22	chr4:3369023-3369073	HEEpiC	esophagus:	n/a
23	chr4:3369023-3369073	PrEC	prostate:	n/a
24	chr4:3369023-3369073	HNPCEpiC	eye:	n/a
25	chr4:3369023-3369073	AoSMC	blood vessel:	n/a
26	chr4:3369023-3369073	GM06990	blood:	n/a
27	chr4:3369023-3369073	RPTEC	kidney:	n/a
28	chr4:3369023-3369073	HPAEpiC	pulmonary alveolar:	n/a
29	chr4:3369023-3369073	U87	brain:	n/a
30	chr4:3369023-3369073	HRCEpiC	kidney:	n/a
31	chr4:3369023-3369073	Jurkat	blood:	n/a
32	chr4:3369023-3369073	AG04449	skin:	fetal
33	chr4:3369023-3369073	ECC-1	luminal epithelium:	n/a
34	chr4:3369023-3369073	HEK293	kidney:	embryo
35	chr4:3369023-3369073	A549	lung:	n/a
36	chr4:3369023-3369073	BE2_C	brain:	n/a
37	chr4:3369023-3369073	Hela-S3	cervix:	n/a
38	chr4:3369023-3369073	LNCaP	prostate:	n/a
39	chr4:3369023-3369073	AG09309	skin:	n/a
40	chr4:3369023-3369073	SK-N-MC	brain:	n/a
41	chr4:3369023-3369073	Caco-2	colon:	n/a
42	chr4:3369023-3369073	HL-60	blood:	n/a
43	chr4:3369023-3369073	HCF	heart:	n/a
44	chr4:3369023-3369073	HCM	heart:	n/a
45	chr4:3369023-3369073	SK-N-SH_RA	brain:	n/a
46	chr4:3369023-3369073	AG04450	lung:	fetal
47	chr4:3369023-3369073	HRE	kidney:	n/a
48	chr4:3369023-3369073	HMEC	breast:	n/a
49	chr4:3369023-3369073	Hepatocyte	liver:	n/a
50	chr4:3369023-3369073	IMR90	lung:	fetal

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:3368401..3370679-chr4:3386543..3390085,3	MCF-7	breast:
2	chr4:3365608..3368928-chr4:3369932..3375344,5	MCF-7	breast:
3	chr4:3368324..3371112-chr4:3371223..3374209,2	MCF-7	breast:
4	chr4:3367776..3369729-chr4:3369770..3372285,2	K562	blood:

No data

Variant related genes	Relation type
RGS12	TF binding region
RGS12	CpG island
ENSG00000159788	chromatin interactions

Extended variants
information (count: 129 )
Associated
traits (count: 56 )

Variant overlapped rSNPs/rCNVs (count:129 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557807420	chr4:3367805-3367806	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs75445063	chr4:3367807-3367808	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs10155402	chr4:3367856-3367857	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs568056534	chr4:3367865-3367866	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs190097371	chr4:3367932-3367933	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
6	rs540065680	chr4:3367959-3367960	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs116583736	chr4:3368025-3368026	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs571026784	chr4:3368072-3368073	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs144173715	chr4:3368137-3368138	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs192745151	chr4:3368144-3368145	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs556852871	chr4:3368164-3368165	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs541069293	chr4:3368178-3368179	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
13	rs535477462	chr4:3368207-3368208	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
14	rs76932357	chr4:3368212-3368213	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
15	rs572431012	chr4:3368213-3368214	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
16	rs573414972	chr4:3368245-3368246	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
17	rs557847260	chr4:3368256-3368257	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
18	rs543775511	chr4:3368257-3368258	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
19	rs6819202	chr4:3368264-3368265	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs184681745	chr4:3368266-3368267	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
21	rs562441960	chr4:3368290-3368291	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
22	rs532831775	chr4:3368296-3368297	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
23	rs16844209	chr4:3368300-3368301	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs541446594	chr4:3368327-3368328	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
25	rs6843312	chr4:3368332-3368333	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs189199347	chr4:3368391-3368392	Weak transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
27	rs34052318	chr4:3368400-3368401	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs140447879	chr4:3368406-3368407	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
29	rs533516031	chr4:3368423-3368424	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
30	rs550444419	chr4:3368428-3368429	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs116256752	chr4:3368438-3368439	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs180843887	chr4:3368457-3368458	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs555453646	chr4:3368488-3368489	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs566031733	chr4:3368498-3368499	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs549615011	chr4:3368519-3368520	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs3129334	chr4:3368526-3368527	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
37	rs557784066	chr4:3368558-3368559	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs10026577	chr4:3368573-3368574	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs539242859	chr4:3368594-3368595	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs550160741	chr4:3368640-3368641	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs186587825	chr4:3368652-3368653	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs555977194	chr4:3368653-3368654	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs576238205	chr4:3368676-3368677	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs542080666	chr4:3368680-3368681	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs561848528	chr4:3368739-3368740	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs571964299	chr4:3368747-3368748	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs571605499	chr4:3368748-3368749	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs372741659	chr4:3368764-3368765	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs111343084	chr4:3368793-3368794	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs564167053	chr4:3368796-3368797	Weak transcription Genic enhancers Enhancers Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:56)

Disease	PMID	Source
Retinitis pigmentosa	18421352	CNVD
Wolf-Hirschhorn syndrome	19259404	CNVD
Bladder cancer	19242612	CNVD
Breast cancer	19242612	CNVD
Congenital anomalies of the kidney and urinary tract	19242612	CNVD
abnormal development	18461090	CNVD
Olfactory neuroblastoma	18408657	CNVD
Wilms tumour	21544195	CNVD
Melanoma	20688739	CNVD
Colorectal cancer	16272173	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17603634	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Colorectal cancer	19359472	CNVD
Neuroblastoma	17533364	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Cancer	21637783	CNVD
Melanoma	21693616	CNVD
Squamous cell cancer	21044232	CNVD
Colorectal cancer	20709793	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Non-small cell lung cancer	21044232	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	17387387	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Cervical cancer	21062161	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Neuroblastoma	18923191	CNVD
small cell lung cancer	20016488	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Developmental delay	21147756	CNVD
Urothelial carcinoma	21177765	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Lung cancer	18438408	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD
Schizophrenia	21399695	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:167 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:3334000-3370600	Weak transcription	Right Atrium	heart
2	chr4:3354800-3368200	Weak transcription	Cortex derived primary cultured neurospheres	brain
3	chr4:3355200-3368400	Weak transcription	Fetal Intestine Small	intestine
4	chr4:3356600-3368000	Weak transcription	Fetal Intestine Large	intestine
5	chr4:3358800-3369000	Weak transcription	Fetal Lung	lung
6	chr4:3360400-3370000	Weak transcription	Primary T helper cells fromperipheralblood	blood
7	chr4:3360600-3370000	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
8	chr4:3361400-3370000	Weak transcription	HSMM	muscle
9	chr4:3362800-3369200	Weak transcription	HSMMtube	muscle
10	chr4:3363600-3368400	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
11	chr4:3363600-3371000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
12	chr4:3364800-3368400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
13	chr4:3364800-3370400	Weak transcription	Pancreas	Pancrea
14	chr4:3364800-3370400	Weak transcription	NHLF	lung
15	chr4:3364800-3370600	Weak transcription	Esophagus	oesophagus
16	chr4:3365000-3369000	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
17	chr4:3365000-3371000	Weak transcription	H9 Cell Line	embryonic stem cell
18	chr4:3365400-3368200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
19	chr4:3365400-3368400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
20	chr4:3365600-3370400	Weak transcription	Gastric	stomach
21	chr4:3365800-3370000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
22	chr4:3365800-3370000	Weak transcription	Duodenum Mucosa	Duodenum
23	chr4:3366000-3368800	Enhancers	Liver	Liver
24	chr4:3366000-3369000	Weak transcription	Fetal Thymus	thymus
25	chr4:3366000-3370200	Weak transcription	Primary T cells from cord blood	blood
26	chr4:3366000-3370400	Weak transcription	Thymus	Thymus
27	chr4:3366000-3370600	Weak transcription	Colonic Mucosa	Colon
28	chr4:3366200-3368800	Weak transcription	Spleen	Spleen
29	chr4:3366200-3369600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
30	chr4:3366400-3368200	Weak transcription	Lung	lung
31	chr4:3366400-3369800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
32	chr4:3366400-3370000	Weak transcription	Brain Cingulate Gyrus	brain
33	chr4:3366400-3370200	Weak transcription	Stomach Smooth Muscle	stomach
34	chr4:3366400-3370400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
35	chr4:3366400-3370600	Weak transcription	Adipose Nuclei	Adipose
36	chr4:3366600-3370000	Weak transcription	Skeletal Muscle Female	skeletal muscle
37	chr4:3366600-3370600	Weak transcription	Primary hematopoietic stem cells	blood
38	chr4:3366800-3369000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
39	chr4:3366800-3369200	Weak transcription	Brain Hippocampus Middle	brain
40	chr4:3366800-3370600	Weak transcription	Skeletal Muscle Male	skeletal muscle
41	chr4:3366800-3372200	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
42	chr4:3367000-3368000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr4:3367000-3368000	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr4:3367000-3370000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
45	chr4:3367000-3370000	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
46	chr4:3367000-3371200	Enhancers	Fetal Brain Male	brain
47	chr4:3367200-3369200	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
48	chr4:3367200-3370400	Weak transcription	Brain Anterior Caudate	brain
49	chr4:3367400-3368600	Enhancers	Fetal Heart	heart
50	chr4:3367400-3371000	Weak transcription	Fetal Kidney	kidney

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links